SCHEMBL1306858

SCHEMBL1306858

CC(CCCC=C(COc1cccc2ccccc12)C(=O)NC1CCN(C(C)C)CC1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ P2RX3 P56373 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ CASP3 P42574 3/20 0.36
▸ CASP1 P29466 2/20 0.36
▸ CASP7 P55210 2/20 0.36
▸ CASP8 Q14790 2/20 0.36
▸ PREP P48147 1/20 0.36
▸ F10 P00742 4/20 0.36
▸ CASP6 P55212 1/20 0.36
▸ SLC6A1 P30531 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1306121 0.96 KMT2A (0.37) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL1306843 0.91 KMT2A (0.37) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL1307235 0.91 P2RX3 (0.40) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL1308301 0.90 KMT2A (0.48) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL1308082 0.90 KMT2A (0.40) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL1306271 0.89 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL1306268 0.89 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL1307084 0.89 P2RX3 (0.41) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL1307949 0.87 P2RX3 (0.50) P2RX3
SCHEMBL1306855 0.87 CNR2 (0.39) ALDH1A1KMT2AMEN1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8053435-B2 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2011-11-08 — — US disclosed
Send feedback